CRISPR Therapeutics Plans Cell Therapy Facility in Framingham, Massachusetts
06/29/2020
“We look forward to building a state-of-the-art manufacturing facility, which will accelerate our programs and allow us to scale for commercial supply. We are thankful for the support from the City of Framingham and the Commonwealth of Massachusetts, and we look forward to bringing our facility online rapidly,” said Samarth Kulkarni, Ph.D., Chief Executive Officer of CRISPR Therapeutics. “In addition to building out this internal manufacturing capacity, we will continue to work closely with our key manufacturing partners globally."
As the facility becomes fully operational, the Company expects to hire up to approximately 100 full-time employees. The new facility is being designed to provide GMP manufacturing according to the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) regulations and guidelines to support clinical supply and commercial product upon potential regulatory approval.
The company has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer AG, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in London, United Kingdom.
Project Announcements
Alltech Expands Jessamine County, Kentucky, Manufacturing Operations
07/30/2025
Liatris Expands Rockville, Maryland, Manufacturing Operations
07/30/2025
China-Based Eco King Solutions Plans Robbinsville, North Carolina, Production Operations
07/30/2025
Hood Container Upgrades West Feliciana Parish, Louisiana, Operations
07/29/2025
MR6 Tech Services Plans Huguley, Alabama, Manufacturing Operations
07/29/2025
Adient Plans Normal, Illinois, Production Operations
07/29/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
In Focus: AI Is Changing Incentives Math
Q2 2025
-
Optimizing Your Rail-Served Transportation Network: Strategy Before Steel
Q2 2025
-
How to Choose the Right Site for Your Factory in 2025’s Volatile Landscape
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
Tariffs, Talent, and U.S. Expansion
Q3 2025
-
First Person: David Robey, Co-CEO of QTS Data Centers
Q2 2025